3 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow DTX: new trials by email Literature Review of DTX trials Research Report on DTX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 120 | 2026-11-17 | 2026-11-12 |
| A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors CAN04 (nadunolimab), mFOLFOX, DTX - Advanced Solid Tumors, Colorectal Cancer | Phase 1 / Phase 2 | Completed | Cantargia AB | 40 | 2021-09-22 | 2023-07-03 |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma Nivolumab, 5-FU, CDDP - Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 1 | Completed | National Cancer Center, Japan | 37 | 2019-05-07 | 2025-05-31 |
| Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer mogamulizumab, Docetaxel - Non-Small Cell Lung Cancer | Phase 1 | Completed | Kyowa Kirin, Inc. | 13 | 2015-01-01 | 2024-09-19 |
Carcinoma, Non-Small-Cell Lung (2) · Biliary Tract Neoplasms (1) · Carcinoma (1) · Carcinoma, Adenoid Cystic (1) · Colorectal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Paranasal Sinus Neoplasms (1) · Prostatic Neoplasms (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Cantargia AB (1) · Kyowa Kirin, Inc. (1) · National Cancer Center, Japan (1) · National Cancer Institute (NCI) (1)
United States (2) · France (1) · Japan (1) · Spain (1)
Charalampos Floudas, M.D. (1) · Ignacio Garcia-Ribas, MD, PhD (1) · Ken Kato, MD/PhD (1) · Michael Kurman (1)